Drugs / Flupentixol-Melitracen
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06945237 | Apr → Aug 2025 | gastroesophageal reflux disease | RenJi Hospital | Completed | No outcome recorded |
| — | NCT06931223 | Apr → Sep 2025 overdue | dyspepsia | RenJi Hospital | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Flupentixol-Melitracen | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06931223 ↗ |